Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 9;20(9):640-645.
doi: 10.20892/j.issn.2095-3941.2023.0211.

CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice

Mengyuan Yang #  1 , Ziheng Xu #  1 , Mi Mi  1 , Yuwei Ding  1 , Yuefen Pan  2 , Ying Yuan  1   3   4   5 , Weijing Sun  6 , Shanshan Weng  1   3   4   5
Affiliations
Editorial

CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice

Mengyuan Yang et al. Cancer Biol Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflicts of interest are disclosed.

Figures

Figure 1
Figure 1
A diagram summarizing CSCO guideline updates. The numbers in brackets represent the number of treatment lines recommended by the corresponding regimen. *Pembrolizumab, envafolimab, serplulimab, tislelizumab, and nivolumab + ipilimumab are preferred. &Trastuzumab + pertuzumab or trastuzumab + lapatinib are recommended.
See this image and copyright information in PMC

References

    1. Zheng RS, Zhang SW, Sun KX, Chen R, Wang SM, Li L, et al. Cancer statistics in China, 2016. Zhonghua Zhong Liu Za Zhi. 2023;45:212–20. - PubMed
    1. Jiang Y, Yuan H, Li Z, Ji X, Shen Q, Tuo J, et al. Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data. Cancer Biol Med. 2021;19:175–86. - PMC - PubMed
    1. Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325:669–85. - PubMed
    1. Yao J, Zhen Y, Fan J, Gong Y, Ye Y, Guo S, et al. Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population. Cancer Biol Med. 2022;19:707–32. - PMC - PubMed
    1. Dong C, Ding Y, Weng S, Li G, Huang Y, Hu H, et al. Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020. Chinese J Cancer Res. 2021;33:302–7. - PMC - PubMed

Publication types

LinkOut - more resources